中国现代药物应用
中國現代藥物應用
중국현대약물응용
CHINESE JOURNAL OF MODERN DRUG APPLICATION
2014年
14期
18-19,20
,共3页
原发性高血压%2型糖尿病%心律失常%临床疗效
原髮性高血壓%2型糖尿病%心律失常%臨床療效
원발성고혈압%2형당뇨병%심률실상%림상료효
Primary hypertension%Type 2 diabetes mellitus%Arrhythmia%Clinical effect
目的探究原发性高血压合并2型糖尿病患者的心律失常临床表现以及对此类患者的治疗方案。方法原发性高血压合并2型糖尿病患者66例设为观察组,仅有原发性高血压患者134例为对照组,对比两组研究对象心律失常构成比的差异;对观察组患者应用对症治疗方案,对照组采用常规降压治疗。观察两组临床治疗效果。结果观察组患者出现心房颤动59.1%以及房室传导阻滞19.7%等事件概率相对较高,而对照组患者出现室性早搏事件50.7%更高;观察组患者接受治疗后收到满意的临床治疗效果。结论原发性高血压合并2型糖尿病患者在临床上最常见心律失常表现为心房颤动,对此类患者应进行及时有效的治疗,能够收到突出的临床效果且不会出现严重不良反应,值得临床推广。
目的探究原髮性高血壓閤併2型糖尿病患者的心律失常臨床錶現以及對此類患者的治療方案。方法原髮性高血壓閤併2型糖尿病患者66例設為觀察組,僅有原髮性高血壓患者134例為對照組,對比兩組研究對象心律失常構成比的差異;對觀察組患者應用對癥治療方案,對照組採用常規降壓治療。觀察兩組臨床治療效果。結果觀察組患者齣現心房顫動59.1%以及房室傳導阻滯19.7%等事件概率相對較高,而對照組患者齣現室性早搏事件50.7%更高;觀察組患者接受治療後收到滿意的臨床治療效果。結論原髮性高血壓閤併2型糖尿病患者在臨床上最常見心律失常錶現為心房顫動,對此類患者應進行及時有效的治療,能夠收到突齣的臨床效果且不會齣現嚴重不良反應,值得臨床推廣。
목적탐구원발성고혈압합병2형당뇨병환자적심률실상림상표현이급대차류환자적치료방안。방법원발성고혈압합병2형당뇨병환자66례설위관찰조,부유원발성고혈압환자134례위대조조,대비량조연구대상심률실상구성비적차이;대관찰조환자응용대증치료방안,대조조채용상규강압치료。관찰량조림상치료효과。결과관찰조환자출현심방전동59.1%이급방실전도조체19.7%등사건개솔상대교고,이대조조환자출현실성조박사건50.7%경고;관찰조환자접수치료후수도만의적림상치료효과。결론원발성고혈압합병2형당뇨병환자재림상상최상견심률실상표현위심방전동,대차류환자응진행급시유효적치료,능구수도돌출적림상효과차불회출현엄중불량반응,치득림상추엄。
Objective To explore the clinical manifestation of arrhythmia in patients with primary hypertension and type 2 diabetes mellitus and treatment methods for such patients. Methods Selected 66 patients with primary hypertension and type 2 diabetes as the observation group, 134 cases of primary hypertension patients as the control group, compared arrhythmia ratio difference of two groups;the observation group received symptomatic treatment, control group received conventional antihypertensive therapy, observed clinical therapeutic effect of two groups. Results Atrial fibrillation, atrioventricular block and other event probability in observation group were relatively high, while ventricular premature beat event was high in the control group;curative effect in observation group was satisfied. Conclusion Atrial fibrillation is the most common manifestations for patients with primary hypertension and type 2 diabetes, timely and effective treatment can receive the prominent clinical effect with no serious adverse reaction, so it is worthy clinical promotion.